Cardiovascular disease (CVD) has emerged as a severe illness worldwide. Currently, the
top ten causes of death in the world include ischemic heart disease according to the Global …

Abstract Coronary Artery Disease (CAD) remains the leading cause of death in the
developed world. The advent of drug-eluting Bio-resorbable Stents (BRSs) heralded a …

There has been a great evolution in the development of coronary stents in order to avoid
both restenosis and thrombosis. Improvements have led to improvements in the design and …

Drug-coated balloon (DCB) technology was developed to deliver the antiproliferative drugs
to the vessel wall without leaving any permanent prosthesis or durable polymers. The …

Although magnesium alloy has received tremendous attention in biodegradable
cardiovascular stents, the poor in vivo corrosion resistance and limited endothelialization …

Objectives: This study sought to describe the frequency and clinical impact of acute scaffold
disruption and late strut discontinuity of the second-generation Absorb bioresorbable …

Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal
stents (BMS) because of their better ability to control restenosis. However, recognized …

Background Endovascular stents and flow diverter stents (FDS) have revolutionized the
treatment of intradural aneurysms; however, the need for dual anti-platelet treatment (DAPT) …

Controlled drug eluting cardiovascular scaffolds (CDECS) have received significant interest
in human healthcare compared to conventional drug eluting cardiovascular scaffolds …

Cardiovascular diseases continue to be a major contributor to illness and death on a global
scale, and the implementation of stents has given rise to a revolutionary transformation in …